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Background. Several pregnancies have been reported after embolization of uterine artery.This procedure is an accepted nonsurgical
treatment for symptomatic uterine fibroids but its safety in women desiring future childbearing is not well established. Case
Report. We present a 40-year-old woman with leiomyomata who became pregnant after previously undergone uterine artery
embolization for three times. The placenta was previa and the fetus was in transverse position. She had a cesarean delivery of
an appropriately grown fetus at 37 weeks, which was followed by uterine atony requiring hysterectomy. Conclusion. Although
pregnancy-related outcomes remain understudied, the available reports evidence that pregnancies after uterine artery embolization
may be at significantly increased risk for postpartum hemorrhage, cesarean delivery, abnormal placentation, and malpresentation.
In patients who are undergoing this type of treatment and contemplating pregnancy, the possibility of adverse complications should
be taken in consideration and women should be appropriately advised.
1. Introduction
Uterine fibroids are one of the most common benign tumors,
with a prevalence of 30% among women of reproductive
age. Although most women are asymptomatic, there are
others that experience bothersome bulk-related symptoms
like pelvic pain, pelvic pressure, urinary frequency, and
abnormal uterine bleeding [1]. Uterine artery embolization
(UAE) is a nonsurgical treatment option for these women
and who wish to retain their uterus and avoid surgery [2].
Recommendation of UAE in women desiring pregnancy is
controversial since there are concerns about its effects on
fertility and pregnancy [3].
This paper reports a case of pregnancy and its outcomes
in a woman who had previously submitted to three uterine
artery embolizations for symptomatic leiomyomata.
2. Case Presentation
We present a case of a 40-year-old woman, gravida 4
para 1, with antenatal surveillance of her pregnancy in our
institution. Her first pregnancy and labor occurred normally,
fourteen years ago. Some years later, she started experience
dysmenorrhea, pelvic pain, and heavy menstrual bleeding.
The diagnosis of leiomyomata was made by ultrasonography
and magnetic resonance imaging (MRI), showing a uterine
volume of 580 cc with a dominant intramural fibroid of 105 cc
volume in the anterior wall. She suffered two miscarriages
after this diagnosis. After counseling about her different
options of treatment, she always refused any type of surgery,
trying to preserve her uterus and expecting a future preg-
nancy.Then, uterine artery embolizationwas performedwith
decrease in fibroid size of 24% after 6 months and improve-
ment of symptoms. However, one year after, the symptoms
recurred and uterinemyomas returned to a previous size. She
undergone for more 2 UAE in another center. The procedure
was repeated in the second time because only 30% degree
of fibroid ischemia was achieved after the first embolization.
Moreover, MRI revealed some contributing circulation from
the left ovarian artery.
Three months after embolization she became pregnant
spontaneously. On antenatal ultrasound scans several uterine
intramural fibroids were evident including the dominant
one placed at the lower segment of anterior wall measuring
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Figure 1: Large intramural leiomyoma protruding from the anterior
lower segment (after dissection of anterior pseudocapsule).
about 65 × 60mm. The placenta was previa and the fetus
was at transverse situation. For these reasons and because of
vaginal bleeding incident, a cesarean section was performed
at 37 weeks of gestation. Intraoperatively the lower segment
was thickened due to underneath leiomyoma. A longitudinal
hysterotomy was needed to access the amniotic sac. A 2970 g
female fetus was delivered, with Apgar scores of 5 and 8 at 1
and 5 minutes, respectively. The placenta was delivered man-
ually. After uterine contraction was noted, the prominence
of the large leiomyoma with about 10 cm size in the anterior
lower segment (Figure 1) and respective myomectomy was
performed. A prophylactic Bakri balloon was left inside of
endometrial cavity prior to complete hysterorrhaphy in three-
layer suture. The remaining uterus was increased in size due
to the presence of other smaller intramural leiomyomas, but
its tonus was consistent.
Two hours later on postoperative recovery room, she
developed atonic hemorrhage and became hemodynamically
instable. A total hysterectomy was performed as a life-
saving measure (Figure 2). During surgery the patient was
transfused with red blood cells, fresh frozen plasma, and
platelets, in order to control the disseminated intravascular
coagulopathy. Histopathology of the uterus showed adeno-
myosis, interstitial and subserous leiomyomas, and signs of
previous embolization. The placenta showed no histopatho-
logical alterations.
The patient recovered well postoperatively and was dis-
charged home on postoperative day 12.
3. Discussion
Uterine artery embolization was first described by Ravina
in 1995 and has been shown to be an effective alternative
treatment for symptomatic uterine leiomyomata. Outcomes
data regarding women who desire future fertility are less
clear and limited [4]. This case demonstrates that pregnancy
after embolization is possible and can occur soon after the
procedure. McLucas showed recently that pregnancy is a
viable option for women undergoing UAE. In his review, the
total pregnancy rate (pregnancies achieved amongst women
under 40 who desired pregnancy) was 63.4% and 48% having
successful term pregnancies [5].
The safety of pregnancy has not been established either.
Several case series of pregnancies following UAE have
Figure 2: Uterus after postcesarean hysterectomy (median suture of
hysterorrhaphy is seen).
reported some adverse outcomes. Our patient index had a
pregnancy complicated by placenta previa, fetal malpresenta-
tion, cesarean delivery, and postpartum hemorrhage. Walker
and McDowell in a series of 56 completed pregnancies after
UAE for fibroids have reported placenta previa rate of 14.3%,
cesarean rate of 72.7%, and postpartum hemorrhage rate of
18% [6]. A large multicentric trial from Ontario reported
abnormal placentation in 12.5% of cases [1]. Another series of
16 viable pregnancies among 671 women underwent UAE for
fibroids and reported a cesarean rate of 88% and postpartum
hemorrhage rate of 18% [7]. Goldberg et al. in 2002 reviewed
all pregnancy reports to date in addition to their 2 additional
cases. Among 23 pregnant women whose indication for
embolization was symptomatic leiomyomata, there was a
22% rate of malpresentation, 65% cesarean delivery rate,
and a 9% rate of postpartum hemorrhage [4]. Theoretically,
the devascularization of the myometrium resulting from the
embolization procedure can affect its ability to successfully
contract following delivery [4]. On the other hand, there
is a high association between leiomyomata and postpartum
hemorrhage [8]. In our case, the presence of residual leiomy-
omas was certainly a major contributing factor to uterine
atony and postpartum hemorrhage requiring hysterectomy,
despite prior embolization. In the same way, it confers a
similar risk to placenta previa, fetal malpresentation and
cesarean delivery [8]. Homer and Saridogan meta-analyzed
227 women with fibroids that achieved pregnancy after UAE.
The cesarean section rate (66%) and postpartum hemorrhage
rate (13.9%) were statistical significantly higher in post-UAE
pregnancies than in fibroid-containing pregnancies (48.5%
and 2.5%, resp.). Rate of malpresentation was similar in both
groups [9].
Thepresence of ovarian-uterine anastomoses that provide
collateral blood flow to the uterus (showed by MRI after the
procedure) may have been the cause of partial failure of UAE
and thus the persistence of residual leiomyomas [10], showing
an unsuccessful UAE, giving the patient an increased risk.
Women who are undergoing this type of treatment and
contemplating pregnancymust be adequately informed about
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potential complications. If residual uterine fibroids persist, it
may influence the main obstetric outcomes, regardless of the
potential effect of embolization on pregnancy.
Conflict of Interests
The authors declare that there is no conflict of interests
regarding the publication of this paper.
References
[1] G. Pron, E. Mocarski, J. Bennett, G. Vilos, A. Common, and
L. Vanderburgh, “Pregnancy after uterine artery embolization
for leiomyomata: the ontario multicenter trial,” Obstetrics and
Gynecology, vol. 105, no. 1, pp. 67–76, 2005.
[2] K. Firouznia,H.Ghanaati, A.H. Jalali, andM. Shakiba, “Uterine
artery embolization for treatment of symptomatic fibroids: a
review of the evidence,” Iranian Red Crescent Medical Journal,
vol. 15, no. 12, Article ID e16699, 2013.
[3] Society of Obstetricians and Gynaecologists of Canada, “Uter-
ine fibroid embolization—SOGC clinical practice guidelines,”
Journal of Obstetrics & Gynaecology, vol. 26, no. 10, pp. 899–911,
2004.
[4] J. Goldberg, L. Pereira, and V. Berghella, “Pregnancy after
uterine artery embolization,” Obstetrics & Gynecology, vol. 100,
no. 5, part 1, pp. 869–872, 2002.
[5] B. McLucas, “Pregnancy following uterine artery embolization:
an update,” Minimally Invasive Therapy & Allied Technologies,
vol. 22, no. 1, pp. 39–44, 2013.
[6] W. J.Walker and S. J. McDowell, “Pregnancy after uterine artery
embolization for leiomyomata: a series of 56 completed preg-
nancies,” The American Journal of Obstetrics and Gynecology,
vol. 195, no. 5, pp. 1266–1277, 2006.
[7] T. T. Carpenter and W. J. Walker, “Pregnancy following uterine
artery embolisation for symptomatic fibroids: a series of 26
completed pregnancies,”British Journal ofObstetrics andGynae-
cology, vol. 112, no. 3, pp. 321–325, 2005.
[8] G. I. Qidwai, A. B. Caughey, and A. F. Jacoby, “Obstetric
outcomes in women with sonographically identified uterine
leiomyomata,” Obstetrics & Gynecology, vol. 107, no. 2, part 1,
pp. 376–382, 2006.
[9] H. Homer and E. Saridogan, “Uterine artery embolization for
fibroids is associated with an increased risk of miscarriage,”
Fertility and Sterility, vol. 94, no. 1, pp. 324–330, 2010.
[10] J. Lopera, R. Suri, G. M. Kroma, A. Garza-Berlanga, and J.
Thomas, “Role of interventional procedures in obstetrics/gyne-
cology,” Radiologic Clinics of North America, vol. 51, no. 6, pp.
1049–1066, 2013.
Submit your manuscripts at
http://www.hindawi.com
Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
MEDIATORS
INFLAMMATION
of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Behavioural 
Neurology
Endocrinology
International Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Disease Markers
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
BioMed 
Research International
Oncology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Oxidative Medicine and 
Cellular Longevity
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
PPAR Research
The Scientific 
World Journal
Hindawi Publishing Corporation 
http://www.hindawi.com Volume 2014
Immunology Research
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Journal of
Obesity
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
 Computational and  
Mathematical Methods 
in Medicine
Ophthalmology
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Diabetes Research
Journal of
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Research and Treatment
AIDS
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Gastroenterology 
Research and Practice
Hindawi Publishing Corporation
http://www.hindawi.com Volume 2014
Parkinson’s 
Disease
Evidence-Based 
Complementary and 
Alternative Medicine
Volume 2014
Hindawi Publishing Corporation
http://www.hindawi.com
